25-hydroxyvitamin-d-2 and Pancreatic-Neoplasms

25-hydroxyvitamin-d-2 has been researched along with Pancreatic-Neoplasms* in 2 studies

Other Studies

2 other study(ies) available for 25-hydroxyvitamin-d-2 and Pancreatic-Neoplasms

Article	Year
Circulating concentrations of vitamin D in relation to pancreatic cancer risk in European populations. International journal of cancer, 2018, 03-15, Volume: 142, Issue:6 Topics: 25-Hydroxyvitamin D 2; Aged; Calcifediol; Case-Control Studies; Europe; Female; Follow-Up Studies; Humans; Incidence; Male; Middle Aged; Pancreatic Neoplasms; Prospective Studies; Risk Assessment; Seasons	2018
[Magnetic resonance cholangiopancreatography: diagnostic significance in malignant diseases of bile and pancreatic ducts]. Acta chirurgica Iugoslavica, 2009, Volume: 56, Issue:4 Magnetic resonance cholangiopancreatography (MR CP) is a relatively new, noninvasive method in patients with pancreaticobiliary diseases, which is comparable to invasive endoscopic retrograde cholangiopancreatography (ERCP). One of the most common indications for MRCP is malignant obstruction of the bile and pancreatic ducts. Standard imaging protocol includes routine abdominal study followed by a sequence for MRCP adapted to each of the patients and site of the malignant process. MRCP is a simple to perform, does not exposure the patients to radiation, requires no anesthesia, is less operator dependent and allows better visualization of ducts proximal to an obstruction. Thus, during one examination only, it is possible to assess not only pancreaticobiliary system but also abdominal structures, which increases diagnostic value of MR and is therefore, optimal method in evaluation of these patients. Topics: 25-Hydroxyvitamin D 2; Bile Duct Neoplasms; Cholangiopancreatography, Magnetic Resonance; Humans; Pancreatic Ducts; Pancreatic Neoplasms	2009

Article

Year

Circulating concentrations of vitamin D in relation to pancreatic cancer risk in European populations.

International journal of cancer, 2018, 03-15, Volume: 142, Issue:6

Topics: 25-Hydroxyvitamin D 2; Aged; Calcifediol; Case-Control Studies; Europe; Female; Follow-Up Studies; Humans; Incidence; Male; Middle Aged; Pancreatic Neoplasms; Prospective Studies; Risk Assessment; Seasons

2018

[Magnetic resonance cholangiopancreatography: diagnostic significance in malignant diseases of bile and pancreatic ducts].

Acta chirurgica Iugoslavica, 2009, Volume: 56, Issue:4

Magnetic resonance cholangiopancreatography (MR CP) is a relatively new, noninvasive method in patients with pancreaticobiliary diseases, which is comparable to invasive endoscopic retrograde cholangiopancreatography (ERCP). One of the most common indications for MRCP is malignant obstruction of the bile and pancreatic ducts. Standard imaging protocol includes routine abdominal study followed by a sequence for MRCP adapted to each of the patients and site of the malignant process. MRCP is a simple to perform, does not exposure the patients to radiation, requires no anesthesia, is less operator dependent and allows better visualization of ducts proximal to an obstruction. Thus, during one examination only, it is possible to assess not only pancreaticobiliary system but also abdominal structures, which increases diagnostic value of MR and is therefore, optimal method in evaluation of these patients.

Topics: 25-Hydroxyvitamin D 2; Bile Duct Neoplasms; Cholangiopancreatography, Magnetic Resonance; Humans; Pancreatic Ducts; Pancreatic Neoplasms

2009